Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Smith

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Pharmacology|November 15, 2003
Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletionPatrick F Smith, Brent M Booker, Patrick Creaven, et al.
Angiology|May 17, 2006
Gemcitabine and acute myocardial infarction--a case reportFadi M Bdair, Susan P Graham, Patrick F Smith, et al.
Antiviral Therapy|January 11, 2018
A pharmacokinetic/viral kinetic model to evaluate treatment of chronic HCV infection with a non-nucleoside polymerase inhibitorLaetitia Canini, Annabelle Lemenuel-Diot, Barbara J Brennan, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotypeBrian T Tsuji, Christof von Eiff, Pamela A Kelchlin, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2008
In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureusBrian T Tsuji, Jenny C Yang, Alan Forrest, et al.
Antiviral Therapy|November 12, 2015
Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infectionLaetitia Canini, Jeremie Guedj, Anushree Chatterjee, et al.
Clinical and Translational Science|October 5, 2022
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized studyDavid Kallend, Jay Mason, Patrick F Smith, et al.
Pharmacotherapy|August 16, 2013
Effect of ritonavir-boosted danoprevir, a potent hepatitis C virus protease inhibitor, on the pharmacokinetics of methadone in healthy subjects undergoing methadone maintenance therapySebastian A Moreira, Peter N Morcos, Mercidita T Navarro, et al.
Clinical Pharmacology and Therapeutics|March 28, 2022
Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status QuoKarthik Venkatakrishnan, Neeraj Gupta, Patrick F Smith, et al.
Antiviral Therapy|October 17, 2014
A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCVLaetitia Canini, Anushree Chatterjee, Jeremie Guedj, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Pharmacology|November 15, 2003
Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletionPatrick F Smith, Brent M Booker, Patrick Creaven, et al.
Angiology|May 17, 2006
Gemcitabine and acute myocardial infarction--a case reportFadi M Bdair, Susan P Graham, Patrick F Smith, et al.
Antiviral Therapy|January 11, 2018
A pharmacokinetic/viral kinetic model to evaluate treatment of chronic HCV infection with a non-nucleoside polymerase inhibitorLaetitia Canini, Annabelle Lemenuel-Diot, Barbara J Brennan, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotypeBrian T Tsuji, Christof von Eiff, Pamela A Kelchlin, et al.
The Journal of Antimicrobial Chemotherapy|April 11, 2008
In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureusBrian T Tsuji, Jenny C Yang, Alan Forrest, et al.
Antiviral Therapy|November 12, 2015
Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infectionLaetitia Canini, Jeremie Guedj, Anushree Chatterjee, et al.
Clinical and Translational Science|October 5, 2022
An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers: A phase I, randomized studyDavid Kallend, Jay Mason, Patrick F Smith, et al.
Pharmacotherapy|August 16, 2013
Effect of ritonavir-boosted danoprevir, a potent hepatitis C virus protease inhibitor, on the pharmacokinetics of methadone in healthy subjects undergoing methadone maintenance therapySebastian A Moreira, Peter N Morcos, Mercidita T Navarro, et al.
Clinical Pharmacology and Therapeutics|March 28, 2022
Asia-Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status QuoKarthik Venkatakrishnan, Neeraj Gupta, Patrick F Smith, et al.
Antiviral Therapy|October 17, 2014
A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCVLaetitia Canini, Anushree Chatterjee, Jeremie Guedj, et al.
Pageof 7